Latest Watcher

Be sure to check out the latest issue of our biweekly newsletter, The Watcher. Regulatory policy articles this time: Toy Recalls Bring Attention to Commission's Inadequacies OMB Manipulates Science in Cost-Benefit Analysis for Ozone Rule Size Matters: Nanotechnologies Present New Challenges

read in full

The House Energy Bill from a Regulatory Perspective

Much has been said about the energy bill (H.R. 3221) the House of Representatives passed on Friday Aug. 4 (here is a recap from The New York Times). The provision receiving the most attention is the renewable electricity standard which would require private utilities to generate 15 percent of their output using renewable resources by 2020. How exactly would this renewable electricity standard work?
  • The Department of Energy (DoE) would retain the regulatory authority of promulgating rules related to the standard and making sure electricity suppliers comply.

read in full

CPSC May Conduct Formal Business Once Again

On Friday, President Bush signed into law S. 4, Implementing Recommendations of the 9/11 Commission Act of 2007. The bill contains a provision which will extend the voting quorum of the Consumer Product Safety Commission (CPSC) by six months. CPSC is an independent regulatory agency responsible for ensuring product safety by promulgating rules and negotiating or forcing recalls.

read in full

White House Attacks Benefits of Smog Reduction

Frank O'Donnell at the Blog for Clean Air has posted on the latest in a series of White House efforts to undermine EPA smog regulations. This time, it's the rule's cost-benefit analysis, wherein the White House Office of Management and Budget tries to underplay the benefits of the rule by attacking the scientific consensus that smog reduction saves lives. Read the post from the Blog for Clean Air here: White House Tampers with EPA Smog Plan

read in full

Senate EPW Works for the Environment, Public

Yesterday was a busy day for the Senate Environment and Public Works Committee. The panel approved legislation which would force EPA to decide on California's request to implement its own vehicle emissions standards. (More on California's request here.) The bill — introduced by Sens. Barbara Boxer (D-CA) and Bill Nelson (D-FL) — would also prevent delay from occurring in the future by giving EPA a 180 day window to decide on future requests.

read in full

Expert Urges FDA to Pull Diabetes Drug from Market

An FDA scientist has recommended the diabetes drug Avandia be pulled from the market for heightening heart attack risks associated with its use. Dr. David Graham made the recommendation during a meeting of a scientific advisory panel which will consider whether the drug should continue to carry FDA approval, according to the Associated Press. In May, a study published in the New England Journal of Medicine called attention to heart problems associated with the drug.

read in full

Questions Remain on Bush Changes to the Regulatory Process

As of July 24, agencies are to be in full compliance with President Bush's recent changes to the regulatory process. But the American people remain in the dark in knowing how these changes will influence the way our government operates. A new analysis by OMB Watch reiterates our concerns with the changes, identifies the many questions that remain, and describes Congress's efforts to mitigate their impact through oversight hearings and proposed legislation. Read the analysis: E.O. 13422: Unanswered and Unaccountable

read in full

Another Risk to Consumer Safety

As we blogged earlier this month, the Consumer Product Safety Commission (CPSC) has been without a quorum since July 2006. This has prevented it from fully addressing all of its responsibilities since January of this year. The agency oversees the safety of thousands of domestic and foreign consumer goods used in homes, schools, and sports.

read in full

Paranoia Strikes Deep

The Associated Press (AP) published a story today noting the decline in the U.S. Environmental Protection Agency's (EPA) criminal enforcement of polluters. According to the article, "The number of the Environmental Protection Agency's criminal investigators has dropped this year to 174, below the 200-agent minimum required by Congress, even as the EPA's overall criminal enforcement budget rose nearly 25 percent over three years to $48 million, according to EPA records." Civil settlements, however, which require spending on pollution controls, are increasing.

read in full

Progress in the FDA? Think again.

You'd think that U.S. Food and Drug Administration (FDA) officials would be willing to listen to their own employees as public confidence in the agency diminishes among a string of regulatory lapses and congressional investigations. However, a BNA report ($) suggests otherwise.

read in full

Pages

Subscribe to The Fine Print: blog posts from Center for Effective Government